Psychiatrie pro praxi – 1/2019

www.psychiatriepropraxi.cz e16 PŘEHLEDOVÉ ČLÁNKY L-TRYPTOFAN – SLOŽKA POTRAVY PŮSOBÍCÍNA DUŠEVNÍ ZDRAVÍ PSYCHIATRIE PRO PRAXI 21. Shaw KA, Turner J, Del Mar C. Tryptophan and 5-Hydroxytryptophan for depressi- on. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003198. doi: 10.1002/14651858.CD003198. 22. Badawy AAB. Tryptophan metabolism in alcoholism. Nutrition research reviews. 2002; 15(1): 123–152. 23. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003; 53(8): 649–659. 24. Jacobsen JPR, Krystal AD, Krishnan KRR, Caron MG. Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends Pharmacol Sci. 2016; 37(11): 933–944. 25. Thomas SR. l-Tryptophan as an antidepressive agent in the management of treatment- -resistant unipolar depression in borderline personality disorder: Three case reports. Advan- ces in Integrative Medicine. 2015; 2(1): 68–71. 26. Hale AS, Procter AW, Bridges PK. Clomipramine, tryptophan and lithium in combina- tion for resistant endogenous depression: seven case studies. Br J Psychiatry. 1987; 151: 213–217. 27. Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM. Preliminary rando- mized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. J Psychiatry Neuros- ci. 2000; 25(4): 337–346.